REZOLUTE, INC.

RZLT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $12.1M $9.4M $4.7M $34.3K $3.5K $24.5K $0
SG&A Expense $8.2M $5.5M $6.0M $5.1M $28.7K $60.1K $22.1K
Operating Income $-20.3M $-15.0M $-10.7M $-5.2M $-6.1M $-393.0K
Operating Margin
Interest Expense $1.6K $5.0K $6.7K $4.2M $568.9K $204.4K
Pretax Income
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income $-20.3M $-14.9M $-11.4M $-9.7M $-6.7M $-91.2K $-590.2K
Net Margin
EPS (Basic) $-0.06 $-0.09 $-0.06 $-0.12 $-0.12 $0.00 $0.00
EPS (Diluted) $-0.06 $-0.09 $-0.06 $-0.12 $-0.12 $0.00 $0.00
Shares Outstanding (Basic) 483.6M 319.8M 219.0M 84.5M 55.8M 36.9M 317.6M
Shares Outstanding (Diluted) 483.6M 319.8M 219.0M 84.5M 55.8M 36.9M 317.6M
Dividends Per Share
← Newer Page 2 of 2 Older →